Gritstone bio (GRTS)
(Delayed Data from NSDQ)
$0.74 USD
-0.01 (-0.95%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $0.74 0.00 (0.46%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
GRTS 0.74 -0.01(-0.95%)
Will GRTS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GRTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GRTS
Down -63.39% in 4 Weeks, Here's Why Gritstone bio (GRTS) Looks Ripe for a Turnaround
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
GRTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
Other News for GRTS
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
Gritstone publishes interim results from Phase 1/2 study of SLATE
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
Gritstone presents improvements to EDGE Platform at AACR 2024